Introduction
============

Transthoracic needle biopsiy has emerged over the past 30 years as the invasive procedure of choicefor diagnosing intrathoracic lesions \[[@B1]\]. The technique has proved extremely accurate in the diagnosis of these lesions. With the advent of cross-sectional imaging using CT and sonography, the applications of TNB have expanded to the diagnosis of mediastinal, hilar, chest wall, and pleural lesions. . Diffuse disease and solitary lesions are equally approachable. TNB can avoid (when technically possible) more complex diagnostic interventions such asmediastinoscopy, thoracoscopy and exploratory thoracotomy. This article focuses on the advantages of TNB which is a safe, affordable and quick method to obtain histopathological confirmation of intrathoracic tumors. The instruments used are biopsy guns or needles of varying gauge, lengths, tip configurations, and firing mechanisms. The needle selection depends upon lesion characteristics, type/amount of tissue required, and operator preference.

Material and Methods
====================

The study included a total of 235 consecutive cases of intrathoracic tumors over a period of 4 and a half years (01.01.2011-30.04.2015) in whom a transthoracic needle biopsy was performed in order to obtain a histopathological result.

The guiding method for precise location of the tumor included fluoroscopy (for the first patients of the study), ultrasound, CT scan but mostly a previous CT scan of the patient and the use of anathomical landmarks (what we call a „CT oriented biopsy").

The CT oriented biopsy method was used for the bigger tumors in the proximity of the pleura. In order to certfy the intratumoral location, after the local anesthesia aspiration was performed with the same needle. If no air or blood was aspired into the syringe the intratumoral location was considered to be confirmed and the biopsy was performed following the same trajectory.

The instrumentsusedwerebiopsy guns or needles of varying gauge (14 to 20), lengths (20 to 30 mm), tip configurations, and sampling mechanisms (manual or automathic). The needle selection depended upon lesion characteristics and proximity, operator preference and disponibility of the devices.

Written informed consent was obtained, including consent for possible chest-tube placement. The patient was informed and educated about the procedure, its benefits, and its risks. A special warning was the powerfull sound of the authomatic needle, in order to avoid the sudden movement of the patient.

The next step of the biopsy procedure consists in chosing the trajectory of the needle wich was established by choosing the shortest straight pathway from the skin to the lesion avoiding the vessels (intercostal, subclavian, internal mammary, vena cava and aorta).

The skin site is prepped and draped using a sterile technique. Palpation of underlying anathomical landmarks is very helpful. The procedurewasperformedunder local anesthesiaalone (10 ml of lydocain 1%) withoutsedation in all of the cases. For local anesthesia, a 27-gauge needle is used to inject the anesthetic into the skin and subcutaneous tissues, followed by deeper infiltration of the intercostal muscles.

The biopsy needle is inserted through the skin into the subcutaneous tissues. During needle insertion, one hand should hold the needle at skin level to stabilize and steer the needle. The other hand should hold the device and push gently downward to advance the needle.

After the needle is advanced to the level of the tumor the needle position and angle are

verified with a short segment CT scan (only when the CT scan guidance is used). The firing of the biopsy needle is performed during a small period of apnea (3 to 5 seconds) that we request from the patient. 3 to 6 biopsy passages are made using the same trajectory, until we consider that the specimen is adequate for histopathological diagnosis.

After the biopsy, a short spiral CT is performed to evaluate for complications such as pneumothorax, hemothorax or intrapulmonary hematoma. If the scan is normal the patient may be discharged in the same day or the next day in few particular cases (dispnea, microhemoptysis, local pain).

Usually we do not perform a routine chest X-ray after biopsy unless the clinical signs of complications are revealed.

Results
=======

In the study group of 235 patients the median age was 62 years (ranging from 14 to 86 years) The sex ratio was 3/1 males/females, in accordance with the lung cancer male predominance.

We could obtain a tissue sample in 99% of the cases (in 2 patients the rapid onset of a small pneumothorax after local anesthesia made impossible the biopsy). For the rest of 233 patients, a histopathological confirmation was possible in 82%.

The tumor location was mainly in the lungs, also few other locations were addressed ([1](#F1){ref-type="fig"}).
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For the most of the cases (125 -- 53%), the guiding method was „CT oriented" as we descriebed it above, due to the big size of the tumor and the proximity to the thoracic wall. The other methods included the CT, ultrasound and fluoroscopy ([2](#F2){ref-type="fig"}). The fluoroscopy was the first method that we used for the only reason of high availability but we had to abandon due to the risk of radiation for the patient and the operator and the imperfect location of the tumor. The ultrasound guidance was also used in few cases but the imperfect location of the profound lesions was the reason to abandon it also.Currently we are using only the CT oriented and the CT guided methods.
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The histopathological examination revealed mostly squamous cell carcinoma (72 cases) and adenocarcinoma (52 cases) or malignant tumor with no other specification (41 cases) and other histopathological findings to a lesser extent ([3](#F3){ref-type="fig"}). A molecular study of those tumors is in progress.
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We compared the average age of patients with different tumor types using the ANOVA test, and we found that there are highly significant statistical differences between them (p=0.001). Continuing the analysis with post-hoc tests, we established that patients with squamous carcinoma and adenocarcinoma tend to be older than patients with various other pathologies, and that patients with adenocarcinoma also have the average age greater than patients with malignant tumors with no other specification ([4](#F4){ref-type="fig"}, [1](#T1){ref-type="table"}).
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###### 

Average age of patients with different tumor types

  -------------------- -------------- -------- ---------
  Tumor type           No. of cases   Mean     St.dev.
  Squamous carcinoma   72             63.616   11.326
  Adenocarcinoma       52             65.5     13.429
  Malignant tumor      41             59.744   12.135
  Benign lesion        18             62.24    10.557
  Other pathology      24             53.75    8.46
  -------------------- -------------- -------- ---------

###### 

Gender distribution of patients with different tumor types

  -------------------- ------------- -------------
  Tumor type/Gender    Males         Females
  Squamous carcinoma   55 (76.39%)   17 (23.61%)
  Adenocarcinoma       40 (76.92%)   12 (23.08%)
  Malignant tumor      29 (70.73%)   12 (29.27%)
  Benign lesion        12 (66.67%)   6 (33.33%)
  Other pathology      16 (66.67%)   8 (33.33%)
  -------------------- ------------- -------------

Comparing the gender distribution of the different tumor types, we encountered small differences, but, overall, they were not

statistically significant - the Chi square test result was p=0.775\<0.05 ([5](#F5){ref-type="fig"}, [2](#T2){ref-type="table"}).
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The most frequent complication that we encountered was the pneumothorax which was minor and was treated conservatively in 14 cases (6%) and significant, requiring chest tube placement in 4 cases (2%). The other complications are detailed in the [1](#T1){ref-type="table"}. The mortality of the procedure for the 235 patients was 0.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------- ---------------
  Complication                                                                                                                                                                                         No of cases   \%
  Minor pneumothorax Significant pneumothorax Minor hemoptysis Significant hemoptysis Accidental puncture of the liver                                                  (under fluoroscopy guidance)   14 4 10 1 1   6 2 4 0.5 0.5
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------- ---------------

Analysing the frequency of complications for different guidance methods, we found percentual differences, without any stattistical signification (p Chi square=0.773\>0.05), mainly because for two of the four methods used (fluoroscopy and ultrasound), we had a very small number of investigated patiens ([6](#F6){ref-type="fig"}, [4](#T4){ref-type="table"}).

###### 

Frequency of complications depending on guidance method

  ------------- ------- --------------- -------------------
  Guidance      Total   Complications   Complications (%)
  CT oriented   125     17              13.60%
  CT guided     86      9               10.47%
  Fluoroscopy   20      3               15.00%
  Ultrasound    4       1               25.00%
  Total         235     30              12.77%
  ------------- ------- --------------- -------------------
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Discussion
==========

TNB is a safe minimal invasive procedure leading to histopathological confirmation of intrathoracic tumors, especially valuable in the diagnosis of small pulmonary nodules \[[@B2]\].

Haaga and Alfidi reported the first case of CT-PTNB in 1976 \[[@B3]\] and, since then, CT guided TNB became the procedure of choice for histopathological confirmation of the intrapulmonary lesions. This procedure has several advantages: high true-positive rate \[[@B4]\], minimal invasiveness, low cost and general availability.

Sihoe et al. \[[@B5]\]concludedafter a study on 443 consecutive adult patients with a lung mass confirmed or suspected to be an early stage primary lung cancer that proceeding to surgery without preoperative diagnosis in selected patients with a suspicious lung mass is safe and can potentially reduce the interval between presentation and surgical management. However, it is important to exclude a benign lesion in order to avoide unnecessary surgery \[[@B6]\].

Yeow et al. found that in CT-guided coaxial cutting needle biopsy, lesion depth is the single predictor for risk of pneumothorax \[[@B7]\]. We had the same results, with no pneumothorax complication encountered in tumors close to the thoracic wall.

Most TNBs are performed on an outpatient basis by using local anesthesia with or without conscious sedation. Virtually any location in the chest can be safely accessed by means of TNB.

Until the interventional radiologists will become interested about TNB, in Romania the thoracic surgeons are performing this procedure.

Conclusion
==========

TNB is generally a safe procedure with limited morbidity and extremely rare mortality. It is an affordable and quick method to obtain histopathological confirmation of intrathoracic tumors. Most TNBs can be performed by using local anesthesia without conscious sedation and virtually any location in the chest can be safely addressed.
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